Pathway network of pyroptosis and its potential inhibitors in acute kidney injury

Ning Li1, Yuru Wang2, Xinyue Wang2

  • 1Institute of Disaster and Emergency Medicine, Tianjin University, Tianjin 300072, China; State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin 300350, China; Tianjin Key Laboratory of Disaster Medicine Technology, Tianjin 300072, China; Wenzhou Safety (Emergency) Institute, Tianjin University, Wenzhou 325000, China.

Pharmacological Research
|December 16, 2021
PubMed

Insights

Pyroptosis, a form of programmed cell death, plays a key role in acute kidney injury (AKI). Targeting pyroptosis pathways offers a promising therapeutic strategy for treating AKI and preventing renal cell death.

Area of Science:

  • Nephrology
  • Cell Biology
  • Immunology

Background:

  • Acute kidney injury (AKI) is a global health concern with limited effective treatments.
  • Renal cell death, particularly tubular epithelial cell (TEC) death, is a primary driver of intrinsic AKI.
  • Various cell death modalities, including apoptosis, necrosis, ferroptosis, and pyroptosis, contribute to AKI pathogenesis.

Purpose of the Study:

  • To review the role of pyroptosis in the mechanisms of AKI.
  • To identify potential therapeutic targets within the pyroptosis pathway for AKI treatment.

Main Methods:

  • Literature review focusing on pyroptosis and its involvement in AKI.
  • Analysis of the NLRP3 inflammasome pathway and its upstream regulators (NF-κB, mitochondrial dysfunction, ER stress).
  • Examination of downstream inflammatory cytokines and their role in pyroptosis-induced AKI.

Main Results:

  • NLRP3 inflammasome activation is a central event in pyroptosis during AKI.
  • Upstream factors like NF-κB signaling, mitochondrial instability, and ER stress influence NLRP3 inflammasome assembly.
  • Activated NLRP3 inflammasome triggers inflammatory responses leading to pyroptosis and AKI.

Conclusions:

  • Pyroptosis is a significant contributor to AKI pathogenesis.
  • Inhibiting key targets in the pyroptosis pathway presents a novel therapeutic avenue for AKI.
  • Understanding pyroptosis mechanisms can lead to the development of improved AKI treatment strategies.

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
168
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
130
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
79
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
87
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
68
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
165